Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding

Cochrane Database of Systematic Reviews

Volumn 2022, Issue 1, 2022, Pages

  Kanno, Takeshi ^a,b   Yuan, Yuhong ^a,c   Tse, Frances ^a,c   Howden, Colin W ^d   Moayyedi, Paul ^a,c   Leontiadis, Grigorios I ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST;

ADULT; ARTICLE; BLOOD TRANSFUSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENDOSCOPIC HEMOSTASIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; STIGMA; STOMACH HEMORRHAGE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; ACUTE DISEASE; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; META ANALYSIS;

ACUTE DISEASE; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HISTAMINE H2 ANTAGONISTS; HUMANS; PROTON PUMP INHIBITORS;

EID: 85122430212     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005415.pub4     Document Type: Article

References (167)

1. Daneshmand TK, Hawkey CJ, Langman MJ, Logan RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ 1992;304:143-7. x-wiley/crsRef/2999801
2. Hawkey GM, Cole AT, McIntyre AS, Long RG, Hawkey CJ. Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut 2001;49:372-9. x-wiley/crsRef/2999803
3. Hulagu S, Demirturk L, Gul S, Yazgan Y, Altin M, Danaci M. The effect of omeprazole or ranitidine intravenous on upper gastrointestinal bleeding. Endoscopy 1994;26:404. x-wiley/crsRef/19609852
4. Hulagu S, Demirturk L, Gul S, Yazgan Y, Altin M, Danaci M. The effect of omeprazole or ranitidine intravenous on upper gastrointestinal bleeding. Endoskopi Journal 1995;2:35-43. x-wiley/crsRef/19609853
5. Hulagu S. Request for additional information about your study [personal communication]. Email to: G Leontiadis 15 October 2005. x-wiley/crsRef/19609854
6. Lau JY, Leung WK, Wu JC, Chan FK, Wong V, Hung LC, et al. Early administration of high dose intravenous omeprazole prior to endoscopy in patients with upper gastrointestinal bleeding: a double blind placebo controlled randomized trial. Gastroenterology 2005;128(Suppl 4):A347. x-wiley/crsRef/19609855
7. Lau JY, Leung WK, Wu JC, Chan FK, Wong VW, Chiu PW, et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. New England Journal of Medicine 2007;356:1631-40. x-wiley/crsRef/2999807
8. Tsoi KK, Lau JY, Sung JJ. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding. Gastrointestinal Endoscopy 2008;67:1056-63. x-wiley/crsRef/19609856
9. Naumovski-Mihalic S, Katicic M, Colic-Cvlje V, Bozek T, Prskalo M, Sabaric B, et al. Intravenous proton pump inhibitor in ulcer bleeding in patients admitted to an intensive care unit. Gastroenterology 2005;128 Suppl 4:W1578. x-wiley/crsRef/2999809
10. Wallner G, Ciechanski A, Wesolowski M, Sory A, Misiuna P. Treatment of acute upper gastrointestinal bleeding with intravenous omeprazole or ranitidine. European Journal of Clinical Research 1996;8:235-43. x-wiley/crsRef/2999811
11. Al-Sabah S, Barkun AN, Herba K, Adam V, Fallone C, Mayrand S, et al. Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding. Gastroenterology 2008;135(5):1790-2. x-wiley/crsRef/2999813
12. Andrews CN, Levy A, Fishman M, Hahn M, Atkinson K, Kwan P, et al. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high risk stigmata: a multicentre comparative study. Canadian Journal of Gastroenterology 2005;19(11):667-71. x-wiley/crsRef/2999815
13. Andriulli A, Loperfido S, Focareta R, Leo P, Fornari F, Garripoli A, et al. High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study. American Journal of Gastroenterology 2008;103(12):3011-18. x-wiley/crsRef/16801156
14. Avgerinos A, Sgouros S, Viazis N, Vlachogiannakos J, Papaxoinis K, Bergele C, et al. Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective randomized placebo controlled trial. Scandinavian Journal of Gastroenterology 2005;40(5):515-22. x-wiley/crsRef/2999817
15. Bai G, Hu FL, Lu DH, Qin J. Efficacy of intravenous administration of omeprazole in the treatment of upper gastrointestinal haemorrhage caused by peptic ulcer and acute gastric mucosal lesion. Chinese Journal of Clinical Pharmacology 1995;11:206-9. x-wiley/crsRef/2999819
16. Bai Y, Chen DF, Wang RQ, Chen YX, Shi RH, Tian DA, et al. Intravenous esomeprazole for prevention of peptic ulcer rebleeding: a randomized trial in Chinese patients. Advances in Therapy 2015;32(11):1160-76. x-wiley/crsRef/16801158
17. Bajaj JS, Dua KS, Hanson K, Presberg K. Prospective randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Digestive Diseases and Sciences 2007;52(9):2190-4. x-wiley/crsRef/2999821
18. Barkun AN, Sung JJ, Kuipers EJ, Mossner J, Jensen DM, Stuart R, et al. Intravenous esomeprazole for prevention of peptic ulcer re-bleeding in a predominantly Caucasian population: results on clinical benefits and hospital resource use. Gastroenterology 2009;136(5 Suppl 1):A43. x-wiley/crsRef/16801160
19. Belei O, Olariu L, Puiu M, Jinca C, Dehelean C, Marcovici T, et al. Continuous esomeprazole infusion versus bolus administration and second look endoscopy for the prevention of rebleeding in children with a peptic ulcer. Revista Espanola de Enfermedades Digestivas 2018;110(6):352-357. x-wiley/crsRef/16801162
20. Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomised controlled trial. Digestion 1990;45(4):217-25. x-wiley/crsRef/2999823
21. Cao JJ, Zhang J, Zhu W, Zhang W. Comparative recent effectiveness of Losec and famotidine in treating peptic ulcer complicated with hemorrhage. Modern Journal of Integrated Traditional Chinese and Western Medicine 2008;17(6):826-7. x-wiley/crsRef/16801164
22. Chan WH, Khin LW, Chung YF, Goh YC, Ong HS, Wong WK. Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding. British Journal of Surgery 2011;98(5):640-644. x-wiley/crsRef/16801166
23. Chen CC, Wang HP, Liou JM, Lee CY, Fang YJ, Han ML, et al. Standard- versus high-dose proton pump inhibitor in peptic ulcer bleeding after combined endoscopic hemostasis. Journal of Gastroenterology and Hepatology 2010;25:A22. x-wiley/crsRef/16801168
24. Chen CC, Lee JY, Fang YJ, Hsu SJ, Han ML, Tseng PH, et al. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers. Alimentary Pharmacology and Therapeutics 2012;35(8):894-903. x-wiley/crsRef/16801170
25. Chen CC, Fang YJ, Lee JY, Chung CS, Chou CK, Hsu YC, et al. Oral versus intravenous proton pump inhibitors in preventing peptic ulcer rebleeding after endoscopic hemostasis. Journal of Gastroenterology and Hepatology 2015;30:5. x-wiley/crsRef/16801172
26. Cheng HC, Kao AW, Chuang CH, Sheu BS. The efficacy of high and low dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Digestive Diseases and Sciences 2005;50(7):1194-1201. x-wiley/crsRef/2999825
27. Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS. Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastrointestinal Endoscopy 2009;70(3):433-439. x-wiley/crsRef/19586676
28. Cheng HC, Yang HB, Chang WL, Sheu BS. Prolonged low-dose omeprazole infusion for 7 days can reduce peptic ulcer re-bleeding for high-risk co-morbid patients. Gastroenterology 2009;136(5 Suppl 1):A43. x-wiley/crsRef/16801176
29. Cheng HC, Yang HB, Chang WL, Yeh YC, Chen WY, Tsai YC, et al. Prolonged low-dose omeprazole infusion for 7 days can reduce peptic ulcer re-bleeding for high-risk co-morbid patients. Journal of Gastroenterology and Hepatology 2009;24:A27. x-wiley/crsRef/16801178
30. Cheng HC, Wu CT, Chang WL, Chen WY, Cheng WC, Tsai YC, et al. Oral double dose esomeprazole after 3-day iv form improves control of peptic ulcer bleeding. Journal of Gastroenterology and Hepatology 2013;28:88. x-wiley/crsRef/16801180
31. Cheng HC, Wu CT, Chang WL, Cheng WC, Chen WY, Sheu BS. Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study. Gut 2014;63(12):1864-72. x-wiley/crsRef/16801182
32. Choi KD, Kim N, Jang I, Park YS, Cho JY, Kim JR, et al. Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea. Journal of Gastroenterology and Hepatology 2009;24(10):1617-1624. x-wiley/crsRef/16801184
33. Chu XQ, Jia LS. Effects of omeprazole and ranitidine on the treatment of peptic ulcer hemorrhage. Journal of Gastroenterology and Hepatology 1993;8(Suppl 2):S239. x-wiley/crsRef/2999827
34. Chwiesko A, Charkiewicz R, Niklinski J, Milewski R, Dabrowski A. Influence of CYP2C19 genetic polymorphisms and Helicobacter pylori infection on efficacy of omeprazole treatment in patients with nonvariceal upper gastrointestinal tract bleeding: a prospective, randomized clinical study. Gastroenterology 2013;144(5 Suppl 1):S506. x-wiley/crsRef/16801186
35. Chwiesko A, Charkiewicz R, Niklinski J, Luczaj W, Skrzydlewska E, Milewski R, et al. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: a randomized prospective study. Journal of Digestive Diseases 2016;17(9):588-99. x-wiley/crsRef/16801188
36. Colin R, Michel P, Sallerin V. Comparison of the efficacy of lansoprazole and ranitidine in the prevention of early relapse in people with upper gastrointestinal ulcerative haemorrhage with a high risk of early recurrence of rebleeding. A double blind multi centre study. Gastroenterolgie Clinique et Biologique 1993;17:A105. x-wiley/crsRef/2999829
37. Costamagna G, Mutignani M, Perri V, Colombo GM, Bruni A, Gabbrielli A, et al. Lansoprazole in preventing bleeding relapse in upper gastrointestinal non variceal bleeding. Gatroenterology 1998;114(Suppl):A95. x-wiley/crsRef/2999831
38. Cui L, Li C, Wang X, Yan Z, He X, Gong S. The therapeutic effect of high-dose esomeprazole on stress ulcer bleeding in trauma patients. Chinese Journal of Traumatology 2015;18(1):41-43. x-wiley/crsRef/16801190
39. Demetrashvili ZM, Lashkhi IM, Ekaladze EN, Kamkamidze GK. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding. Georgian Medical News 2013;223:7-11. x-wiley/crsRef/16801192
40. Dovas A. Medical treatment of active bleeding of upper gastrointestinal tract: omeprazole or H2 antagonists? A comparative study. Annales Medicales 1992:169-72. x-wiley/crsRef/2999833
41. Elphick DA, Riley SA. Omeprazole before endoscopy in patients with gastrointestinal bleeding. New England Journal of Medicine 2007;357:303. x-wiley/crsRef/2999835
42. Fasseas P, Leybishkis B, Rocca G. Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by repeat early endoscopy. International Journal of Clinical Practice 2001;55:661-4. x-wiley/crsRef/2999837
43. Felder LR, Barkin JS. A comparison of omeprazole and placebo for bleeding peptic ulcer. Gastrointestinal Endoscopy 1998;47(5):428-9. x-wiley/crsRef/2999839
44. Fried R, Beglinger C, Meier R, Stumpf J, Adler G, Schepp W, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding. Gut 1999;45(Suppl V):A100. x-wiley/crsRef/2999841
45. Gao Z, Deng C, Yi J. The effect of omeprazole on upper gastrointestinal haemorrhage. Acta Academaie Medicinae Hubei 1995;16:223-5. x-wiley/crsRef/2999843
46. Garrido Serrano A, Giraldez A, Trigo C, Leo E, Guil A, Marquez JL. Intravenous proton-pump for acute peptic ulcer bleeding: is profound acid suppression beneficial to reduce the risk of rebleeding? Revista Espanola de Enfermedades Digestivas 2008;100(8):466-9. x-wiley/crsRef/16801194
47. Gashi Z, Joksimovic N, Dragusha G, Bakalli A. The efficacy of PPI after endoscopic hemostasis in patients with bleeding peptic ulcer and role of Helicobacter pylori. Medicinski Arhiv 2012;66(4):236-9. x-wiley/crsRef/16801196
48. Goletti O, Sidoti F, Lippolis PV, De Negri F, Cavina E. Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomised controlled trial. Italian Journal of Gastroenterology 1994;26:72-4. x-wiley/crsRef/2999845
49. Hasselgren G. Optimisation of acid suppression for patients with peptic ulcer bleeding. An intra gastric pH-metry study with omeprazole. European Journal of Gastroenterology and Hepatology 1998;10:601-6. x-wiley/crsRef/2999847
50. Hsu YC, Perng CL, Yang TH, Wang CS, Hsu WL, Wu HT, et al. A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding. British Journal of Clinical Pharmacology 2010;69(3):245-51. x-wiley/crsRef/16801198
51. Hung WK, Li VK, Chung CK, Ying MW, Loo CK, Liu CK, et al. Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric PH and recurrent bleeding in peptic ulcers. Australian and New Zealand Journal of Surgery 2007;77(8):677-81. x-wiley/crsRef/2999851
52. Javid G, Zargar SA, U-Saif R, Khan BA, Yatoo GN, Shah AH, et al. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. Journal of Gastroenterology and Hepatology 2009;24(7):1236-43. x-wiley/crsRef/16801200
53. Jensen DM, Pace SC, Soffer E, Comer GM. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a US multicenter randomized double-blind study. American Journal of Gastroenterology 2006;101(9):1991-9. x-wiley/crsRef/2999853
54. Jensen DM, Stuart R, Ahlbom H, Eklund S, Barkun AN, Kuipers EJ, et al. Is there a subgroup of patients with Forrest IB (oozing) peptic ulcer bleeding at increased risk of re-bleeding? Gastrointestinal Endoscopy 2009;69(5):AB118. x-wiley/crsRef/16801202
55. Jensen DM, Eklund S, Persson T, Ahlbom H, Stuart R, Barkun AN, et al. Reassessment of rebleeding risk of Forrest IB (oozing) peptic ulcer bleeding in a large international randomized trial. American Journal of Gastroenterology 2017;112(3):441-6. x-wiley/crsRef/16801204
56. Kan MY, Hung WK, Li KM, Ying WL, Liu KT, Chan CM. Randomized trial comparing pantoprazole infusion and bolus on recurrent bleeding and gastric pH in peptic ulcers. ANZ Journal of Surgery 2008;78(S1):A78. x-wiley/crsRef/16801206
57. Këlliçi I, Kraja B, Mone I, Prifti S. Role of intravenous omeprazole on non-variceal upper gastrointestinal bleeding after endoscopic treatment: a comparative study. Medicinski Arhiv 2010;64(6):324-7. x-wiley/crsRef/19586678
58. Keyvani L, Murthy S, Leeson S, Targownik LE. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics 2006;24(8):1247-55. x-wiley/crsRef/2999855
59. Kim JI, Cheung DY, Cho SH, Park SH, Han JY, Kim JK, et al. Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized controlled trial. Digestive Diseases and Sciences 2007;52(12):3371-6. x-wiley/crsRef/2999857
60. Kim HK, Kim JS, Kim TH, Kim CW, Cho YS, Kim SS, et al. Effect of high-dose oral rabeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Gastroenterology Research and Practice 2012;2012:[8 p.]. x-wiley/crsRef/16801210 [DOI: 10.1155/2012/317125]
61. Kuipers EJ, Sung JJ, Barkun A, Mossner J, Jensen D, Stuart R, et al. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding. Advances in Therapy 2011;28(2):150-9. x-wiley/crsRef/16801212
62. Laine L, Shah A, Bemanian S. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers. Gastroenterology 2008;134(7):1836-41. x-wiley/crsRef/16801214
63. Lau JY, Sung JJ, Lind T, Persson T, Eklund S. High-dose intravenous proton pump inhibitors for prevention of recurrent peptic ulcer bleeding in Chinese and Western populations: rebleeding is not influenced by ethnicity. Gastroenterology 2014;146(5 Suppl 1):S-210. x-wiley/crsRef/16801216
64. Lau J, Lind T, Persson T, Eklund S. Effect of baseline characteristics on response to proton pump inhibitors in patients with peptic ulcer bleeding. Journal of Digestive Diseases 2017;18(2):99-106. x-wiley/crsRef/16801218
65. Lee KK, You JH, Wong IC. Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer. Gastrointestinal Endoscopy 2003;57:160-4. x-wiley/crsRef/2999861
66. Lee HJ, Kim JI, Cheung DY, Cho SH, Park SH. Comparison between oral vs. intravenous administration of proton pump inhibitors [Abstract]. Journal of Gastroenterology and Hepatology 2011;26:263. x-wiley/crsRef/16801220
67. Lee HJ, Kim JI, Cheung DY, Kim TH, Kim SS, Kim BW, et al. Comparison between oral and intravenous administration of proton pump inhibitor dosing with 24 hours intragastric pH: a prospective, randomized, controlled trial. Gastroenterology 2012;142(5 Suppl 1):S463. x-wiley/crsRef/16801222
68. Liang CM, Lee JH, Kuo YH, Wu KL, Chiu YC, Chou YP, et al. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis. BMC Gastroenterology 2012;12:28. x-wiley/crsRef/16801224
69. Lin HJ. Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding [comment]. Alimentary Pharmacology & Therapeutics 2007;25(3):343-4. x-wiley/crsRef/2999863
70. Lin HJ, Tsai JJ. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers. Gastroenterology 2008;135(5):1804-5. x-wiley/crsRef/16801226
71. Liu RH, Wei CM, Wang XP, Yin ZZ. The efficacy of Losec versus famotidine in the treatment of bleeding duodenal ulcer. Shanghai Medical and Pharmaceutical Journal 2002;23(7):199-201. x-wiley/crsRef/2999865
72. Liu N, Liu L, Zhang H, Gyawali PC, Zhang D, Yao L, et al. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding. Journal of Gastroenterology and Hepatology 2012;27(9):1473-9. x-wiley/crsRef/16801228
73. Lohsiriwat D, Saejong R, Lohsiriwat V, Tongsai S, Thamlikitkul V. Comparison of the efficacy and safety between generic intravenous omeprazole (Zefxon) and original omeprazole (Losec) in the adjunct treatment of non-variceal upper gastrointestinal bleeding in Siriraj Hospital. Journal of the Medical Association of Thailand 2011;94(11):1357-64. x-wiley/crsRef/16801230
74. Lu LS, Lin SC, Kuo CM, Tai WC, Tseng PL, Chang KC, et al. A real world report on intravenous high-dose and non-high-dose proton-pump inhibitors therapy in patients with endoscopically treated high-risk peptic ulcer bleeding. Gastroenterology Research and Practice 2012;2012:858612. x-wiley/crsRef/16801232
75. Maculotti L, Pradella P. Comparison between ranitidine, famotidine and omeprazole in the treatment of bleeding duodenal ulcer. Minerva Chirurgica 1995;50(3):279-81. x-wiley/crsRef/2999867
76. Magallen MG, Arguillas MO. The effects of pantoprazole iv drip versus pantoprazole iv bolus on stigmata of recent hemorrhage among patients with nonvariceal upper gastrointestinal bleeding. Gastrointestinal Endoscopy 2011;73(4 Suppl 1):AB120-1. x-wiley/crsRef/16801234
77. Masjedizadeh AR, Hajiani E, Alavinejad P, Hashemi SJ, Shayesteh AA, Jamshidian N. High dose versus low dose intravenous pantoprazole in bleeding peptic ulcer: a randomized clinical trial. Middle East Journal of Digestive Diseases 2014;6(3):137-43. x-wiley/crsRef/16801236
78. Mehmedovic-Redzepovic A, Mesihovic R, Prnjavorac B, Kulo A, Merlina K. Hematologic and laboratory parameters in patients with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors. Medicinski Glasnik 2011;8(1):151-7. x-wiley/crsRef/16801238
79. Mesihovic R, Vanis N, Mehmedovic A, Gornjakovic S, Gribajcevic M. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding. Medicinski Arhiv 2009;63(6):323-7. x-wiley/crsRef/16801240
80. Mostaghni AA, Hashemi SA, Heydari ST. Comparison of oral and intravenous proton pump inhibitor on patients with high risk bleeding peptic ulcers: a prospective, randomized, controlled clinical trial. Iranian Red Crescent Medical Journal. 2011;13(7):458-63. x-wiley/crsRef/16801242
81. Motiei A, Sebghatolahi V. Efficacy comparison of divided and infusion intravenous pantoprazole methods after endoscopic therapy in patients with acute gastrointestinal bleeding. Advanced Biomedical Research 2017;6:120. x-wiley/crsRef/16801244
82. Munkel L, French L. Treatment of bleeding peptic ulcers with omeprazole. Journal of Family Practice 1997;45(1):20-1. x-wiley/crsRef/2999869
83. Murthy S, Keyvani L, Leeson S, Targownik LE. Intravenous versus high-dose oral proton pump inhibitor therapy after endoscopic haemostasis of high risk lesions in patients with acute nonvariceal upper gastrointestinal bleeding. Digestive Diseases and Sciences 2007;52(7):1685-90. x-wiley/crsRef/2999871
84. Nehme O, Barkin JS. Recurrent ulcer bleeding: is intravenous omeprazole the solution? American Journal of Gastroenterology 2001;96(2):594-5. x-wiley/crsRef/2999873
85. Ortí E, Canelles P, Quiles F, Zapater R, Cuquerella J, Ariete V, et al. Does the antisecretory agent used affect the evolution of upper digestive hemorrhage? Revista Espanola De Enfermedades Digestivas 1995;87:427-30. x-wiley/crsRef/19586680
86. Perez Flores R, Garcia Molinero MJ, Herrero Quiros C, Blasco Colmenarejo MM, Caneiro Alcubilla E, Garcia-Rayo Somoza M, et al. The treatment of upper digestive hemorrhage of peptic origin: intravenous ranitidine versus intravenous omeprazole. Revista Española de Enfermedades Digestivas 1994;86(3):637-41. x-wiley/crsRef/2999877
87. Phulpoto JA, Bhatti ZA, Shaikh A. Comparison of oral and intravenous proton pump inhibitor in patients with high risk bleeding peptic ulcers. Rawal Medical Journal 2013;38(1):7-10. x-wiley/crsRef/16801246
88. Rattanasupar A, Sengmanee S. Comparison of high dose and standard dose proton pump inhibitor before endoscopy in patients with non-portal hypertension bleeding. Journal of the Medical Association of Thailand 2016;99(9):988-95. x-wiley/crsRef/16801248
89. Robinson K, Lam T, Haas B, Reidt S, Bartlett K, Jancik J. Pantoprazole continuous infusion versus intermittent bolus in the treatment of upper gastrointestinal bleeding. Critical Care 2017;21(1 Suppl 1):58. Abstract P487. x-wiley/crsRef/16801250
90. Sakurada T, Kawashima J, Ariyama S, Kani K, Takabayashi H, Ohno S, et al. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers. Digestive Endoscopy 2020;24(2):93-9. x-wiley/crsRef/16801252
91. Savides TJ, Pratha V. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Gastrointestinal Endoscopy 2001;54(1):130-2. x-wiley/crsRef/2999879
92. Schaffalitzky de Muckadell OB. Acid pump inhibitor before gastroscopy for upper gastrointestinal bleeding. Ugeskrift for Læger 2007;169(35):2903. x-wiley/crsRef/2999881
93. Scheurlen M. Peptic ulcer hemorrhage: IV antacid prevents recurrence. Fortschritte der Medzin 2000;142(45):30. x-wiley/crsRef/2999883
94. Schonekas H, Ahrens H, Pannewick U, Ell C, Koop H, Petritsch W, et al. Comparison of two doses of intravenous pantoprazole in peptic ulcer bleeding. Gut 1999;45(Suppl V):A104. x-wiley/crsRef/2999885
95. Songur Y, Balkarli A, Acarturk G, Senol A. Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding. European Journal of Internal Medicine 2011;22(2):200-4. x-wiley/crsRef/16801254
96. Srinath C. Comparison of omeprazole and placebo for bleeding peptic ulcer. Tropical Gastroenterology 1997;18(3):115-6. x-wiley/crsRef/2999887
97. Sung JY, Chan FK, Lau JW. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with non bleeding visible vessels or adherent clots: a randomised comparison. Annals of Internal Medicine 2003;139:237-43. x-wiley/crsRef/2999889
98. Sung JY, Mossner J, Barkun A, Kuipers EJ, Lau J, Jensen D, et al. Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of peptic ulcer bleed study. Alimentary Pharmacology and Therapeutics 2008;27(8):666-7. x-wiley/crsRef/2999891
99. Sung JY, Barkun A, Kuipers EJ, Mossner J, Jensen DM, Stuart R, et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding. Annals of Internal Medicine 2009;150(7):455-64. x-wiley/crsRef/19586682
100. Sung JJ, Barkun AN, Kuipers EJ, Mossner J, Jensen DM, Stuart R, et al. Effect of type of endoscopic hemostasis and adjuvant intravenous esomeprazole on peptic ulcer re-bleeding. Gastrointestinal Endoscopy 2009;69(5):AB118. x-wiley/crsRef/16801258
101. Sung JJ, Suen BY, Ching J, Chan FK, Wu JC, Chiu PW, et al. Effects of intravenous and oral esomeprazole in prevention of recurrent bleeding from peptic ulcers after endoscopic therapy. Gastroenterology 2012;142(5 Suppl 1):S192-3. x-wiley/crsRef/16801260
102. Sung JJ, Suen BY, Wu JC, Lau JY, Ching JY, Lee VW, et al. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy. American Journal of Gastroenterology 2014;109(7):1005-10. x-wiley/crsRef/16801262
103. Theyventhiran R, Na CS, Bundoi A, Menon J. Pre-emptive proton pump inhibitors (PPIs) then oral vs. IV PPI post-endoscopic haemostasis in peptic ulcer bleed (PUB) East Malaysian patients. Journal of Gastroenterology and Hepatology 2012;27:434. x-wiley/crsRef/16801264
104. Theyventhiran RR, Menon J, Singh M, Bundoi A, Chin SN, Ahmed A, et al. An assessment if the Rockall, Blatchford and AIMS65 scores predict outcome in peptic ulcer bleed (PUB) patients who received a pre-emptive intravenous infusion (IVI) of a proton pump inhibitor (PPI) pre endoscopic hemostasis followed by IVI or oral PPI. Gastroenterology 2013;144(5 Suppl 1):S481. x-wiley/crsRef/19586684
105. Theyventhiran RR, Menon J, Singh M, Chin SN, Bundoi A, Ahmed A, et al. A comparison between intravenous infusion and oral proton pump inhibitors (PPI) following pre-emptive intravenous infusion of a PPI in acute peptic ulcer bleed (PUB) post endoscopic hemostasis. Gastroenterology 2013;144(5 Suppl 1):S80-1. x-wiley/crsRef/16801268
106. Tran HA, Kang E, Becker D. Omeprazole before endoscopy in patients with gastrointestinal bleeding [comment]. New England Journal of Medicine 2007;357(3):303-4. x-wiley/crsRef/2999893
107. Tsai JJ, Hsu YC, Perng CL, Lin HJ. Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection. British Journal of Clinical Pharmacology 2009;67(3):326-32. x-wiley/crsRef/16801270
108. Ucbilek E, Sezgin O, Altintas E. Low dose bolus pantoprazole following successful endoscopic treatment for acute peptic ulcer bleeding is effective: a randomised, prospective, double-blind, double dummy pilot study. Gastroenterology 2013;144(5 Suppl 1):S506. x-wiley/crsRef/16801272
109. Ucbilek E, Altintas OS. Low dose bolus pantoprazole for acute peptic ulcer bleeding is effective. Acta Medica Mediterranea 2015;31(1):91-6. x-wiley/crsRef/16801274
110. Udd M, Miettinen P, Janatuinen E, Heikkinen M, Tarvainen R, Pasanen P, et al. Regular versus high dose omeprazole for peptic ulcer bleeding - prospective randomised double blind study. Annales Chirurgiae et Gynaecologiae 1999;88(2):169. x-wiley/crsRef/2999897
111. Uribarrena R, Bajador E, Simon MA, Sebastian JJ, Gomollon F. Omeprazole and cimetidine in the treatment of upper digestive haemorrhage. Revista Espanola de Enfermedades Digestivas 1994;86:878-83. x-wiley/crsRef/2999899
112. Van Rensburg C, Barkun AN, Racz I, Fedorak R, Bornman PC, Beglinger C, et al. Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. Alimentary Pharmacology & Therapeutics 2009;29(5):497-507. x-wiley/crsRef/16801276
113. Wang Y, Zhang Z, Zhou Y, Wang J, Dai L, Zhang G, et al. Intravenous rabeprazole sodium for treatment of duodenobulbar ulcer bleeding: a multicenter, randomized, double-blind, positive drug parallel-group controlled clinical study. Chinese Journal of Gastroenterology 2014;19(5):275-8. x-wiley/crsRef/16801278
114. Wang WD, Guo BM. Clinical effects of omeprazole vs famotidine for treatment of stress-induced gastrointestinal bleeding in patients with high energy multiple fractures. World Chinese Journal of Digestology 2015;23(3):479-82. x-wiley/crsRef/16801280
115. Wei KL, Tung SY, Sheen CH, Chang TS, Lee IL, Wu CS. Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Journal of Gastroenterology and Hepatology 2007;22(1):43-6. x-wiley/crsRef/2999901
116. Wu N, Wang SJ, Wang SG, Pan GH. Therapeutic efficacy of pantoprazole on upper gastrointestinal hemorrhage. Chinese New Medicine 2001;2(12):1091-2. x-wiley/crsRef/2999903
117. Xuan JL. Loseco compared with famotidine in the treatment of upper gastrointestinal bleeding: clinical analysis of 90 cases. Guangxi Medical Journal 2003;25:529-31. x-wiley/crsRef/2999905
118. Yamada S, Wongwanakul P. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer. Journal of the Medical Association of Thailand 2012;95(3):349-57. x-wiley/crsRef/16801282
119. Ye X, Zhou YY, Jiang Q. Pantoprazole and omeprazole for treating peptic ulcer bleeding: hemostasis effect, adverse reactions and relapse. World Chinese Journal of Digestology 2016;24(28):4008-12. x-wiley/crsRef/16801284
120. Yen HH, Yang CW, Su WW, Wu SS, Chou KC, Hsu YC, et al. Oral vs intravenous proton pump inhibitors for peptic ulcer bleeding, a preliminary report. Gastrointestinal Endoscopy 2011;73(4 Suppl 1):AB228. x-wiley/crsRef/16801286
121. Yen HH, Yang CW, Su WW, Soon MS, Wu SS, Lin HJ. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy. BMC Gastroenterology 2012;12:66. x-wiley/crsRef/16801288 [DOI: 10.1186/1471-230X-12-66]
122. Yilmaz S, Bayan K, Tuzun Y, Dursun M, Canoruc F. A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots. World Journal of Gastroenterology 2006;12(48):7837-43. x-wiley/crsRef/2999907
123. Yin DL, Wang J. Impact of cold weather on peptic ulcer and upper gastrointestinal bleeding and preventive strategies. World Chinese Journal of Digestology 2013;21(34):3914-19. x-wiley/crsRef/16801290
124. Yuksel I, Ataseven H, Koklu S, Ertugrul I, Basar O, Odemis B, et al. Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study. Digestion 2008;78(1):39-43. x-wiley/crsRef/16801292
125. Zargar SA, Javid G, Khan BA, Yattoo GN, Shah AH, Gulzar GM, et al. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. Journal of Gastroenterology and Hepatology 2006;21(4):716-21. x-wiley/crsRef/2999909
126. Abougergi MS, Travis AC, Saltzman JR. The in-hospital mortality rate for upper GI hemorrhage has decreased over 2 decades in the United States: a nation-wide analysis. Gastrointestinal Endoscopy 2015;81(4):882-8.
127. Ali Khan M, Howden CW. The role of proton pump inhibitors in the management of upper gastrointestinal disorders. Gastroenterology & Hepatology 2018;14:169-75.
128. Barkun A, Bardou M. The role of PPI therapy in upper GI tract bleeding. Gastroenterology and Hepatology Annual Review 2006;1:20-4.
129. Barkun AN. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy? Gastrointestinal Endoscopy 2008;67:1064.
130. Barkun AN, Almadi M, Kuipers EJ, Laine L, Sung J, Tse F, et al. Management of nonvariceal upper gastrointestinal bleeding: Guideline recommendations from the International Consensus Group. Annals of Internal Medicine 2019;171(11):805-22.
131. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JB. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. American Journal of Gastroenterology 1999;94(7):1834-40.
132. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
133. Garcia-Tsao G, Sanyal AJ, Grace ND, Practice Guidelines Committee of American Association for Study of Liver Diseases, Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. American Journal of Gastroenterology 2007;102:2086-2102.
134. Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointestinal Endoscopy 1990;36:S8-13.
135. McMaster University (developed by Evidence Prime) GRADEpro GDT. Version accessed prior to 1 January 2022. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.
136. Green FW, Kaplan MM, Curtis LE. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74(Suppl 1):38-43.
137. Healy P, Bolger J, Hickey A, Hill A. Systematic review and meta-analysis of the use of proton pump inhibitors compared to placebo or H2 receptor antagonists in the pre-endoscopy management of upper gastrointestinal bleeding. Irish Journal of Medical Science 2015;184(9 Suppl 1):S402-3.
138. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
139. Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 2002;50:460-4.
140. Huang JQ, Hunt RH. Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician. Best Practice & Research. Clinical Gastroenterology 2001;15:355-70.
141. Kanno T, Iijima K, Abe Y, Koike T, Shimada N, Hoshi T, et al. Peptic ulcers after the Great East Japan earthquake and tsunami: possible existence of psychosocial stress ulcers in humans. Journal of Gastroenterology 2013;48(4):483-90.
142. Kanno T, Iijima K, Koike T, Abe Y, Shimada N, Hoshi T, et al. Accommodation in a refugee shelter as a risk factor for peptic ulcer bleeding after the Great East Japan Earthquake: a case-control study of 329 patients. Journal of Gastroenterology 2015;50(1):31-40.
143. Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. New England Journal of Medicine 1997;336(15):1054-8.
144. Kolkman JJ, Meuwissen SG. A review on treatment of bleeding peptic ulcer. A collaborative task of gastroenterologist and surgeon. Scandinavian Journal of Gastroenterology 1996;31(Suppl 218):16-25.
145. Laine L, Peterson WL. Bleeding peptic ulcer. New England Journal of Medicine 1994;331:717-27.
146. Laine L, Jensen DM. Management of patients with ulcer bleeding. American Journal of Gastroenterology 2012;107:345-60.
147. Lanas A, Chan FK. Peptic ulcer disease. Lancet 2017;390(10094):613-24.
148. Leontiadis GI, Howden CW. Current indications for acid suppressants in Helicobacter pylori-negative ulcer disease. Best Practice & Research. Clinical Gastroenterology 2001;15:401-12.
149. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No: CD002094. [DOI: 10.1002/14651858.CD002094.pub3]
150. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia - a post hoc analysis from the Cochrane Collaboration. Alimentary Pharmacology & Therapeutics 2005;21(9):1055-61.
151. Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. American Journal of Gastroenterology 1997;92:419-24.
152. Low J, Dodds AJ, Biggs JC. Fibrinolytic activity of gastroduodenal secretions-a possible role in upper gastrointestinal haemorrhage. Thrombosis Research 1980;17:819-30.
153. McColl KE. How I manage H. Pylori-negative, NSAID/aspirin-negative peptic ulcers. American Journal of Gastroenterology 2009;104(1):190-3.
154. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869.
155. National Institute for Health and Care Excellence. Acute upper gastrointestinal bleeding in over 16s: management. Clinical guideline 141; June 2012. Available at www.nice.org.uk/guidance/cg141/resources/acute-upper-gastrointestinal-bleeding-in-over-16s-management-pdf-35109565796293.
156. Paimela H, Paimela R, Luosujarvi E, Kivilaakso E. Current features of peptic ulcer disease in Finland. Incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years. Scandanavian Journal of Gastroenterology 2002;37:399-403.
157. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2021.
158. Schünemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from handbook.cochrane.org.
159. Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding. I. Study design and baseline data. Gastrointestinal Endoscopy 1981;27(2):73-9.
160. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
161. Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA), 2nd edition. Copenhagen, Denmark: Copenhagen Trial Unit, 2011; pp. 1-119. Available from www.ctu.dk/tsa. Accessed prior to 1 January 2022.
162. Van Leerdam ME, Vreeburg EM, Rauws EA, Geraedts AM, Tijssen JG, Reitsma JB, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. American Journal of Gastroenterology 2003;98:1494-9.
163. Wong GL, Au KW, Lo AO, Tse YK, Ching JY, To KF, et al. Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori–negative idiopathic bleeding ulcers. Clinical Gastroenterology and Hepatology 2012;10(10):1124-9.
164. Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Digestive Diseases and Sciences 2018;63(5):1286-93.
165. Dorward S, Forman D, Howden CW, Leontiadis GI, Sreedharan A. Proton pump inhibitors (before endoscopic diagnosis) in upper gastrointestinal bleeding. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No: CD005415. [DOI: 10.1002/14651858.CD005415]
166. Dorward S, Sreedharan A, Leontiadis G, Howden C, Moayyedi P, Forman D. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No: CD005415. [DOI: 10.1002/14651858.CD005415.pub2]
167. Sreedharan A, Martin J, Leontiadis GI, Dorward S, Howden CW, Forman D, et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No: CD005415. [DOI: 10.1002/14651858.CD005415.pub3]